It is understood that the binding of CD80 with CTLA-4, a receptor that acts as an important negative regulator of T-cell responses, is favorable for carcinogenesis because cancer cells commonly use the immunosuppressive function of regulatory T cells to avoid immunological attacks [42,43,44]. This evidence concerns the gene CD80 and cancer.